Using Spironolactone for HFpEF Lessens Risk of CV Death Despite Worsening Renal Function
The researcher’s goal was to study the relationship between worsening renal function, spironolactone treatment, and clinical outcomes in patients with heart failure with preserved ejection fraction.
